US Patent 9636388 Multi-indication mRNA cancer immunotherapy
Patent 9636388 was granted and assigned to Morphogenesis, Inc. on May, 2017 by the United States Patent and Trademark Office.
Is a
Date Filed
May 19, 2016
Date of Patent
May 2, 2017
Patent Application Number
15114943
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9636388 Multi-indication mRNA cancer immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
